Pfizer’s gene therapy for hemophilia treatment approved by Health Canada, company says | CBC News

Pfizer said on Wednesday that Canada’s health regulator approved its gene therapy for the treatment of a rare inherited bleeding disorder called hemophilia B ahead of a U.S. decision.